Tau reduction prevents A-induced axonal transport deficits by blocking activation of GSK 3
Tau reduction prevents A-induced axonal transport deficits by blocking activation of GSK 3
复制标题
DOI:
--
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
K. Vossel;Jordan C. Xu;V. Fomenko;T. Miyamoto;Elsa Suberbielle;Joseph A. Knox;Kaitlyn Ho;Daniel H. Kim;Gui-qiu Yu;L. Mucke
中科院分区:
文献类型:
--
作者:
K. Vossel;Jordan C. Xu;V. Fomenko;T. Miyamoto;Elsa Suberbielle;Joseph A. Knox;Kaitlyn Ho;Daniel H. Kim;Gui-qiu Yu;L. Mucke
The Rockefeller University Press $30.00 J. Cell Biol. Vol. 209 No. 3 419–433 www.jcb.org/cgi/doi/10.1083/jcb.201407065 JCB 419 Correspondence to Keith A. Vossel: kvossel@gladstone.ucsf.edu; or Lennart Mucke: lmucke@gladstone.ucsf.edu Abbreviations used in this paper: A, amyloid ; AD, Alzheimer’s disease; ANOVA, analysis of variance; [Ca]i, intracellular calcium; D-AP5, d-()-2amino-5-phosphonopentanoic acid; DIV, day in vitro; DPBS, Dulbecco’s phosphatebuffered saline; GSK3, glycogen synthase kinase 3; GSM, -secretase modulator; hAPP, human amyloid precursor protein; NMDAR, N-methyl-d-aspartate receptor; PS1, presenilin 1; TTX, tetrodotoxin. Introduction